Related Experiment Video
Updated: Aug 11, 2026

08:02
Thin Film Composite Silicon Elastomers for Cell Culture and Skin Applications: Manufacturing and Characterization
Published on: July 3, 2018
Reproductive, teratologic, and mutagenic studies with some polydimethylsiloxanes
Journal of Toxicology and Environmental Health
|July 1, 1976
Summary
Selected polydimethylsiloxanes showed minimal reproductive and developmental effects in animal studies. One material demonstrated no teratogenic or mutagenic potential, indicating a favorable safety profile for these silicone compounds.
Area of Science:
- Toxicology
- Reproductive Toxicology
- Developmental Toxicology
Background:
- Polydimethylsiloxanes (PDMS) are widely used silicones.
- Assessing the reproductive and developmental safety of PDMS is crucial for human health.
- Limited data exists on the specific effects of certain PDMS formulations.
Purpose of the Study:
- To evaluate the reproductive and fetal development effects of selected polydimethylsiloxanes (PDMS) in rats and rabbits.
- To determine the mutagenic potential of a specific PDMS material in mice.
Main Methods:
- Two three-phase reproductive and developmental toxicity studies in rats and rabbits using a 350 cSt PDMS fluid.
- Mutagenicity testing in male mice using a 7 cSt PDMS fluid.
- Teratogenicity studies in rats and rabbits with 7 cSt and 10 cSt PDMS fluids, respectively.
Main Results:
- A dose-related incidence of in utero mortality was observed in rats at 200 and 1,000 mg/kg sc with 350 cSt PDMS in one study; no fetotoxicity was seen in a second study.
- Talipes varus incidence in rabbits at 200 mg/kg sc with 350 cSt PDMS was not considered significant due to higher control rates and absence at higher doses/in companion studies.
- A 7 cSt PDMS fluid was nonteratogenic in rats (oral doses up to 1,000 mg/kg) and nonmutagenic in mice (ip doses of 5 and 10 g/kg).
- A 10 cSt PDMS fluid was nonteratogenic in rabbits (dermal dose of 200 mg/kg).
Conclusions:
- Selected polydimethylsiloxanes (PDMS) demonstrate a low potential for reproductive and developmental toxicity.
- The tested PDMS fluids exhibited no significant teratogenic or mutagenic effects in the conducted animal models.
- Findings support the general safety of these specific PDMS materials in reproductive and developmental contexts.
Related Concept Videos
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

